6M Group LLC reported that Sanofi and Blueprint completed a deal where 229 people were cut.
Public source
Publisher name
Public post
M&A nobody puts in the press release......the layoffs......Biopharma buys, biopharma cuts. **Seven deals **>1,300 jobs wiped out **Losing 80%+ of workforce **Reality che…
Company
6M Group LLC
Simple. NOT EASY. Effective.
- Industry
- Business Consulting and Services
- Location
- Leominster, US
- Company size
- 2–10 employees
About 6M Group LLC
My Philosophy: Simple. NOT EASY. Effective. I help people and businesses cut the noise, focus on what matters, and execute with discipline. Clarity creates speed. Discipline creates results. Energy creates momentum. The right path is usually clear. The hard part is committing to it, showing up with energy, and holding the standard long enough to win. I operate with confidence in my process, intensity when it matters, and standards that elevate the people around me. I’ve spent years inside high‑pressure environments - sales, operations, leadership - and the pattern is always the same: People DON'T fail because they’re incapable. They fail because they’re overwhelmed, distracted, and lack clear direction. My work fixes that. I help teams: - Clarify their priorities - Move with urgency and confidence - Build simple, effective systems - Increase accountability - Improve hiring and talent decisions I bring an energetic, positive, no‑nonsense approach that gets people moving fast and staying focused. If you want to eliminate the noise and start winning with clarity and momentum, let’s connect.
See moreLatest activity
Latest activity from 6M Group LLC
30 signals
Sales & Marketing
6M Group LLC supported AstraZeneca's new #Breztri campaign, which leverages AI-generated animals to promote the triple therapy asthma maintenance inhaler, achieving $1.2B in annual sales and positioning the brand as modern, accessible, and patient-centered.
Presence & Recognition
6M Group LLC noted that Ionis Pharmaceuticals, Inc. has declared themselves a rare-disease powerhouse with the first-ever FDA-approved therapy for Alexander disease.
Capital & Finance
6M Group LLC reported that the U.K. biotech ecosystem saw the Best funding quarter in five years.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Leaman Life Sciences
Leaman Life Sciences is involved in the acquisition of Merida Biosciences by Eli Lilly and Company for up to $2.88bn.
Capital & Finance
Morrissey Goodale LLC
Morrissey Goodale LLC reported a 3.1% increase in total deals compared to the same period in 2025.
Capital & Finance
LAUXERA CAPITAL PARTNERS
LAUXERA CAPITAL PARTNERS published a bottom graph showing M&A deployment returning to its 2019 peak driven by patent cliff worries.
Capital & Finance
Seltek Consultants Ltd
Seltek Consultants Ltd noted that EsoBiotec (AstraZeneca) reached $425M upfront in an acquisition.
Capital & Finance
CY Partners